Immunotherapy‐Induced Type 1 Diabetes Mellitus Causing Diabetic Ketoacidosis: A Case Report and Review of Current Guidelines
ABSTRACT Background Immune checkpoint inhibitors (ICIs) are becoming more frequently used in the treatment of many types of malignant cancers by disinhibiting T‐cell activation, which promotes the destruction of cancer cells. This disinhibition can also result in autoimmune conditions, like endocrin...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-11-01
|
| Series: | Cancer Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cnr2.70058 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|